Vanda Pharmaceuticals reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Akebia Therapeutics 0 0 Mar/2025
Anika Therapeutics 0 0 Mar/2025
AstraZeneca USD 1.98 0.23 Sep/2026
Bristol-Myers Squibb 4.04 0.32 Sep/2026
Eli Lilly 0.58 0.02 Sep/2026
Enanta Pharmaceuticals 0 0 Mar/2025
Heron Therapeutics 0 0 Mar/2025
J&J 1.95 0.11 Sep/2026
Lexicon Pharmaceuticals 0 0 Mar/2025
Merck 2.34 0.28 Sep/2026
Minerva Neurosciences 0 0 Mar/2025
Novartis 3.32 0.22 Sep/2026
Pfizer 6 1.08 Sep/2026
Puma Biotechnology 0 0 Mar/2025
Sangamo BioSciences 0 0 Mar/2025
Sanofi 5.67 0.18 Sep/2026
Takeda 3.46 0.42 Sep/2026
Vanda Pharmaceuticals 0 0 Mar/2025